Lutetium-177 (Lu-177) Pipeline Analysis gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of prostate cancer, NETs, Lung cancer, solid tumors and other conditions. ...
-
How fast the market of your interest is growing?
Key drivers behind the growth..
-
What are your biggest Challenges?Identify the key problems.. -
What are your Revenue pockets?Areas you need to bet.. -
What are your Competitors doing?Know your competitive edge.. -
Who is your Customer?Get Their changing preferences..
what we offer
Report Store
Healthcare is an ever changing domain with an explosion in knowledge and breakthrough discoveries. Hence, it has become a major thrust area for the global giants in the pharmaceutical, biotechnology and medical devices industries and also for corporates involved in research and development of new products.
IQ4I's focus areas in Healthcare include Pharmaceuticals, biotechnology, Medical devices and Healthcare IT. Since these domains cater to humans, they are subject to stringent regulatory mechanisms requiring highly specialized skills in knowledge processing, with superior quality and adherence to global standards.
IQ4I
Latest Reports
This pipeline analysis gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of prostate cancer, NETs, Lung cancer, solid tumors and other conditions.
Increasing radioisotopes application, rise in public awareness, use of SPECT/CT and PET/CT imaging scans (hybrid imaging), and advancements in technology are driving nuclear medicine market growth.
The factors such as growing demand for biologics, increasing investment in research and development (R&D) and expansion of manufacturing facilities, demand for generic pharmaceuticals, rapid growth of medtech industry with increasing disease population are driving the market, Whereas increasing use of single use technologies and advancements in filtration technologies such as development of high capacity membrane filters, changes in designs of filters, advancement in membrane technologies and TFF process technologies are providing immense growth opportunities to the market.
Factors like necessity to curb patient safety threatening and economically straining Healthcare Associated Infections (HAIs), the requisite to sterilize the reusable high risk or critical surgical instruments used in the persistently escalating surgical procedures across the globe, the regulatory mandate of terminal sterilization or aseptic processing of healthcare products before commercialization, increasing trend of outsourcing of sterilization services by the healthcare industry, constant progressive refinements of various sterilization technologies, the gradual transition of medical devices market from reprocessed to the value enhanced single use devices and the necessity to terminally sterilize the huge volume of disposable devices, steadily increasing and advancing healthcare facilities, healthcare industry and research settings across the globe with increased utilization of various sterilization products and the persistently elevating fragile geriatric population burdened with several co-morbidities with increased medical needs and increased vulnerability to HAIs are propelling the sterilization market growth.
The factors such as increasing funding towards the cell based research, increasing focus towards the application 3D cell culture models in in-vitro testing in drug discovery, toxicity testing due to advantages over 2D cell culture system are driving the 3D cell culture market. Whereas, growing focus towards application of 3D cell culture in the personalized and regenerative medicine and advancement is 3D cell culture technologies will provide immense growth opportunities for the 3D cell culture market.
The factors like the increasing trend of outsourcing among the medical device OEMs to enhance the speed to market of their proprietary products economically, the necessity for OEMs to perpetuate their market share and achieve operational efficiency and competitive edge over their peers by gaining timely, economical access to the advanced, scale appropriate and multiple product manufacturing capabilities of CMOs, the need to meet the huge volume medical device demand associated with persistently escalating prevalence of chronic and infectious diseases and varying medical needs of steadily escalating geriatric population, the gradual transition of medical device market to the value enhanced and cost-efficient disposable devices, increase in surgical procedural volume, hospitalizations and developing healthcare facilities across the globe, the requirement of medical device companies to stay abreast in the highly competitive medical device market with technologically advanced medical devices, and the trend of consolidation in the market are propelling the market growth.
The factors, such as, the increase in demand for imaging agent-assisted diagnostic procedures for better visualization due to increase in cardiovascular diseases and cancer, production of radiopharmaceuticals from cyclotrons, increasing access to diagnostic imaging in the emerging markets, increase in the aging population suffering from chronic disease, and usage of hybrid imaging technologies are driving the market growth.
Toxicology is the study of adverse effects that occur in living organisms and its environment due to chemicals, physical or biological substances at ambient exposure levels.
An increase in the prevalence of diabetes, advantages of insulin pumps in the home care setting, and increasing distribution agreements, partnerships and collaboration activities, are the factors driving the market growth.
Increasing demand for minimally invasive surgical procedure leading fast recovery and reduced hospital stays, technological innovations offering a wider scope of applications for endoscopy, the rise in obese population preferring bariatric surgery for weight reduction are the factors driving the market growth.
IQ4I
Latest News
Increasing radioisotopes application, rise in public awareness, use of SPECT/CT and PET/CT imaging scans (hybrid imaging), and advancements in technology are driving nuclear medicine market growth....
IQ4I
Clientele
Offering solutions to >500 clients from the U.S., Europe, Japan, Korea, Singapore and Australia in realizing the market potential and competitive intelligence across healthcare domains (Medical Technologies, Pharmaceutical, Biotech and Life Sciences).
